CervoMed CRVO
NASDAQ CRVO
$2.62 +0.06 (+2.34%)
At close: Aug 21, 2026 · 4:00 PM EDT

CervoMed (CRVO) Receivables - Other (2011 - 2013)

CervoMed (CRVO) posted Receivables - Other of $2020.0 for Q4 2013, down 96.19% sequentially from $53013.0 in Q3 2013, and down 97.19% YoY from $71946.0 in Q4 2012.

CervoMed (CRVO) Receivables - Other (2011 - 2013) Analysis & Trends

CervoMed has reported Receivables - Other for 3 years, with the latest figure at $2020.0 in Q4 2013.

  • Quarterly Receivables - Other fell 97.19% year-over-year to $2020.0 in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $2020.0 (down 97.19% YoY) and the FY2013 annual result came in at $2020.0, down 97.19% from the prior year.
  • Receivables - Other eased to $2020.0 in Q4 2013 per CRVO's latest filing, from $53013.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $682722.0 in Q3 2012 and troughed at $2020.0 in Q4 2013.
  • A 3-year average of $277542.5 and a median of $71946.0 in 2012 frame the typical range for Receivables - Other.
  • The sharpest annual moves came in 2012 and 2013: Receivables - Other increased 6.68% in 2012, then tumbled 97.19% in 2013.
  • Over 3 years, Receivables - Other stood at $640000.0 in 2011, then tumbled by 88.76% to $71946.0 in 2012, then sank by 97.19% to $2020.0 in 2013.
  • According to Business Quant data, Receivables - Other over the past three periods registered $2020.0, $53013.0, and $58693.0 for Q4 2013, Q3 2013, and Q2 2013 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CervoMed 26.64 Mn 26.64 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2013 2,020.00
Dec 31, 2013 2,020.00
Sep 30, 2013 53,013.00
Sep 30, 2013 53,013.00
Jun 30, 2013 58,693.00
Jun 30, 2013 58,693.00
Mar 31, 2013 71,946.00
Mar 31, 2013 71,946.00
Dec 31, 2012 71,946.00
Dec 31, 2012 71,946.00
Sep 30, 2012 682,722.00
Sep 30, 2012 682,722.00
Dec 31, 2011 640,000.00
Dec 31, 2011 640,000.00
Sep 30, 2011 640,000.00
Sep 30, 2011 640,000.00